Carnegie Investment Counsel Grows Position in Procter & Gamble Company (The) $PG

Key Points

• Carnegie Investment Counsel increased its stake in Procter & Gamble by 5.8% in Q2, owning 74,115 shares valued at approximately $11.8 million.
• Procter & Gamble recently disclosed a quarterly dividend of $1.0568 per share, which will be paid on November 17th, with a current yield of 2.8%.
• Procter & Gamble's stock has a consensus rating of "Moderate Buy", with a recent average price target of $171.68 from analysts.

Carnegie Investment Counsel grew its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 5.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,115 shares of the company's stock after buying an additional 4,048 shares during the period. Carnegie Investment Counsel's holdings in Procter & Gamble were worth $11,808,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. Kingstone Capital Partners Texas LLC grew its stake in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Procter & Gamble during the first quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD boosted its position in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the last quarter. Invesco Ltd. increased its holdings in Procter & Gamble by 19.8% in the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC raised its position in Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company's stock worth $280,946,000 after buying an additional 1,674,139 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 3,227 shares of the business's stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares in the company, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 490 shares of the firm's stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the transaction, the insider owned 12,616 shares in the company, valued at approximately $1,920,533.68. This trade represents a 3.74% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 149,763 shares of company stock valued at $23,421,279. Corporate insiders own 0.20% of the company's stock.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $152.62 on Friday. The firm has a market cap of $357.21 billion, a PE ratio of 23.44, a P/E/G ratio of 4.04 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $146.96 and a twelve month high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The business has a 50-day moving average price of $154.66 and a 200 day moving average price of $158.41.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating the consensus estimate of $1.90 by $0.09. The company had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.Procter & Gamble's quarterly revenue was up 3.0% compared to the same quarter last year. During the same period last year, the company earned $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble's dividend payout ratio (DPR) is presently 64.98%.

Analyst Ratings Changes

PG has been the topic of a number of research reports. JPMorgan Chase & Co. cut their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a research note on Friday, October 10th. UBS Group lowered their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a report on Wednesday, October 8th. Raymond James Financial reduced their price objective on Procter & Gamble from $185.00 to $175.00 and set an "outperform" rating for the company in a research note on Monday, October 20th. BNP Paribas Exane lowered their target price on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a research note on Tuesday, September 23rd. Finally, Weiss Ratings reiterated a "hold (c+)" rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $171.68.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.